| Aggression in autism spectrum disorder: presentation and treatment options SE Fitzpatrick, L Srivorakiat, LK Wink, EV Pedapati, CA Erickson Neuropsychiatric disease and treatment 12, 1525, 2016 | 304 | 2016 |
| Fragile X targeted pharmacotherapy: lessons learned and future directions CA Erickson, MH Davenport, TL Schaefer, LK Wink, EV Pedapati, ... Journal of neurodevelopmental disorders 9, 1-14, 2017 | 120 | 2017 |
| A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome LG Hess, SE Fitzpatrick, DV Nguyen, Y Chen, KN Gaul, A Schneider, ... Journal of Developmental & Behavioral Pediatrics 37 (8), 619-628, 2016 | 87 | 2016 |
| Pharmacotherapy for fragile X syndrome: progress to date MH Davenport, TL Schaefer, KJ Friedmann, SE Fitzpatrick, CA Erickson Drugs 76, 431-445, 2016 | 43 | 2016 |
| The neurobehavioral and molecular phenotype of Angelman Syndrome LK Wink, S Fitzpatrick, R Shaffer, S Melnyk, AH Begtrup, E Fox, ... American Journal of Medical Genetics Part A 167 (11), 2623-2628, 2015 | 29 | 2015 |
| High-throughput functional analysis of autism genes in zebrafish identifies convergence in dopaminergic and neuroimmune pathways HW Mendes, U Neelakantan, Y Liu, SE Fitzpatrick, T Chen, W Wu, A Pruitt, ... Cell reports 42 (3), 2023 | 14 | 2023 |
| Pediatric quality of life inventory (PedsQL) in fragile X syndrome SE Fitzpatrick, LM Schmitt, R Adams, EV Pedapati, LK Wink, RC Shaffer, ... Journal of autism and developmental disorders 50, 1056-1063, 2020 | 11 | 2020 |
| Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord. 2017 CA Erickson, MH Davenport, TL Schaefer, LK Wink, EV Pedapati, ... | 11 | |
| Aggression in Autism Spectrum Disorder and Other Neurodevelopmental Disorders LC Politte, SE Fitzpatrick, CA Erickson Aggression: Clinical Features and Treatment Across the Diagnostic Spectrum …, 2019 | 6 | 2019 |
| Challenges in conducting clinical trials for pharmacotherapies in Fragile X syndrome: Lessons Learned CM Harkins, KC Dominick, LK Wink, EV Pedapati, RC Shaffer, ... Pharmaceutical Medicine 31, 235-244, 2017 | 3 | 2017 |
| Medical student patient outreach to ensure continuity of care during the COVID-19 pandemic A Belzer, EM Yeagle, LK Kohlenberg, M Solberg, E Gudbranson, ... Telemedicine Reports 2 (1), 56-63, 2021 | 2 | 2021 |
| Functional Analysis of Autism Genes in Zebrafish Identifies Convergence in Dopaminergic and Neuroimmune Pathways and Pharmacological Candidates. HW Mendes, U Neelakantan, Y Liu, SE Fitzpatrick, T Chen, W Wu, A Pruitt, ... Gazi Medical Journal 35, 2024 | | 2024 |
| High-Throughput Functional Analysis of Autism Genes in Zebrafish Identifies Convergent Pathways HW Mendes, U Neelakantan, Y Liu, S Fitzpatrick, T Chen, W Wu, A Pruitt, ... NEUROPSYCHOPHARMACOLOGY 47 (SUPPL 1), 147-147, 2022 | | 2022 |
| Functional Analysis and Targeted Pharmacological Screens in Zebrafish Mutants of Autism Risk Genes HW Mendes, W Wu, T Chen, D Jin, S Fitzpatrick, U Neelakantan, N Li, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 160-161, 2021 | | 2021 |
| Pediatric Quality-of-Life Inventory in Fragile X Syndrome S Fitzpatrick, L Schmitt, R Adams, EV Pedapati, R Shaffer, J Sage, ... 66th Annual Meeting, 2019 | | 2019 |
| Targeted GABA A Modulation in the Mouse Model of Fragile X Syndrome C Erickson, S Fitzpatrick, M Davenport, E Pedapati, J Sweeney, ... NEUROPSYCHOPHARMACOLOGY 43, S581-S582, 2017 | | 2017 |
| Effects of Sertraline Treatment for Young Children with FXS A Ligsay, LG Hess, S Fitzpatrick, K Lemons Chitwood, J Polussa, ... | | 2015 |
| Dominican Scholar A Ligsay, LG Hess, S Fitzpatrick, KL Chitwood, J Polussa | | |
| Christina M. Harkins, Kelli C. Dominick, Logan K. Wink, Ernest V. Pedapati, Rebecca C. Shaffer, Sarah E Fitzpatrick | | |
Ernest Pedapati, MD, MSCincinnati Children's Hospital Medical CenterBestätigte E-Mail-Adresse bei cchmc.org
